1. Copyright © 2015 by the American Osteopathic Association.
From: Application of Incretin Mimetics and Dipeptidyl Peptidase IV Inhibitors in Managing Type 2 Diabetes Mellitus
J Am Osteopath Assoc. 2007;107(suppl_3):S10-S16.
Figure Legend:
Comparison of the administration routes and physiologic effects of the incretin modulators—incretin mimetics and dipeptidyl peptidase IV inhibitors—in patients with type 2 diabetes mellitus based on compilation of overall incretin studies by the National Diabetes Education Initiative (NDEI). *Data from animal studies. Abbreviations: DPP-IV, dipeptidyl peptidase IV; GLP-1, glucagon-like peptide 1. (Reprinted with permission from the NDEI.)
Date of download: 10/6/2017
Copyright © 2015 by the American Osteopathic Association.
All rights reserved.